bringing evidence into dju-lyn chng 茹玲 account development manager

75
Bringing Evidence into Dju-Lyn Chng 茹茹 Account Development Manager

Upload: aira

Post on 05-Feb-2016

157 views

Category:

Documents


0 download

DESCRIPTION

Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager. What will we cover today?. What is Evidence-Based Medicine? Why is EBM important? What is the traditional method of practicing EBM? How Clinical Evidence fits into the practice of EBM? Case Scenario. - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Bringing Evidence intoDju-Lyn Chng 茹玲Account Development Manager

Page 2: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What will we cover today?

• What is Evidence-Based Medicine?• Why is EBM important?• What is the traditional method of

practicing EBM?• How Clinical Evidence fits into the practice

of EBM?

• Case Scenario

Page 3: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What is evidence based medicine?

“Evidence based medicine is the “conscientious, explicit and judicious use of current best evidence in making decisions about individual patients”.

Sackett DL et al 1996

Page 4: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Patient values

Patientcircumstances

Clinicalexpertise

Best research evidence

EBM

Evidence-based Medicine: How to teach and practice EBM. Straus SE, Richardson WS, Paul Glasziou, Haynes RB. Third Edition. Churchill Livingston: Edinburgh, 2005.

Evidence Based

Medicine

Page 5: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What is not evidence based medicine?

Evidence based medicine does not tell healthcare professionals what to do.

Evidence based medicine identifies management options, and how well they are supported by evidence in defined populations.

Page 6: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Why is evidence based medicine important?

Evidence based medicine allows healthcare professionals to:

• Identify gaps in knowledge• Choose effective treatments• Choose between effective treatments• Choose cost-effective treatments

• Stop using treatments that do not work and / or that harm patients

Page 7: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Different levels of evidence – The Haynes Pyramid

Systems

Summaries

Synopses

Syntheses

Studies

Examples

Computerized decision support

Evidence-based textbooks

Evidence-based journal abstracts

Systematic reviews

Original journal articles

The evolution of Evidence-Basedinformation systems

More time is needed as we go down the pyramid

R Brian Haynes. Of studies, syntheses, synopses, summaries, and systems: the "5S" evolution of information services for evidence-based healthcare decisions. Evidence-Based Medicine 2006;11:162-164.

Page 8: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

PubMed: Studies: 原始研究文獻

Page 9: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

海量的醫學文獻• 8000 articles published per day

• 30 kg of guidelines per family doctor

• 25,000 biomedical journals in print

• 1500 medical articles onto Medline per day

Page 10: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Cochrane systematic reviews: Syntheses: 系統性綜述

Page 11: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Evidence based medicine journal: Synopses: 單篇循證文獻摘要性評述

Page 12: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

BMJ Clinical Evidence: Summaries: 針對臨床問題結合證據的概述

Page 13: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What is BMJ Clinical Evidence?Helping Clinicians Put Evidence Into Practice

Features

• Provides systematic reviews offering evidence on over 3,100 interventions in over 650 clinical situations

• Includes evidence based research sources from over 10,000 peer reviewed articles from Cochrane Library, Medline, Embase and evidence based journals

• Produced by international panel of clinicians using rigorous searching and evaluation methods

• Summary of the best evidence of benefits and harms of interventions

• Updated regularly

• Links to abstracts on PubMed

Page 14: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

實證醫學的五個主要步驟• Assess• Ask clinical question

提出一個可以被回答的問題• Acquire the evidence

檢索文獻資料 • Appraise the evidence

嚴格評價證據的可信度和相關性• Apply the evidence

結合實際作出臨床決策

Page 15: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Traditional Steps of Evidence Based Medicine

• Assess • Ask clinical question• Acquire the evidence• Appraise the evidence• Apply the evidence

Page 16: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

How BMJ Clinical Evidence relates to the steps of EBM?

•“Ask clinical questions”•Review planning

•“Acquire the Evidence”

•Appraise the evidence

•“Apply the Evidence”•Combined into structured summaries

Page 17: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Planning – Ask clinical questions...• PICOT

– Patient – Intervention/Risk factor – Comparison – Outcome

– Type of Study (Systematic reviews? RCTs?)

• Quality parameters– Size of study– Length of follow up– Loss to follow up

Page 18: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Searching – Acquire the evidence...

• PubMed• Medline• Cochrane Reviews• Embase• … and many more

Page 19: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Searching – Acquire the evidence...

Page 20: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Searching – Evidence for benefits of a treatment... But... What about the harms?

• Systematic reviews often do not search for adverse effects (Ernst 2001)

• RCTs are not big enough or long enough to detect many harms

• Published trials including harms data can be difficult to find (Derry 2001)

• Many observational studies to appraise

Page 21: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

How BMJ Clinical Evidence search for harms

• Look for specific adverse effects identified at review planning

• Decide which type of evidence will be appropriate

• RCTs – for expected and common harms that happen soon after treatment

• Unexpected, rare and delayed harms may require case-control/cohort search

Page 22: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Displaying the Benefits and Harms

Page 23: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Information categorised

Page 24: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Detailed evidence for each treatment

Page 25: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Benefits

Page 26: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Harms

Page 27: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Appraisal – appraise the evidence…BMJ Clinical Evidence appraisal criteria

Page 28: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Appraisal – Selection of studies

DO YOU WANT TO INCLUDE THIS ARTICLE? YES NO IF NO, INDICATE REASON FOR EXCLUSION BELOW:Irrelevant/wrong question Not RCTNot Blinded Wrong comparison Too small Wrong intervention Wrong patient group Surrogate Outcome Less than 80% follow upOther (please specify)..........................................................

Page 29: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 30: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Appraisal – BMJ Clinical Evidence

makes the GRADE

Page 31: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What is GRADE?

• Grading of • Recommendations • Assessment, • Development and • Evaluation system for grading evidence

Page 32: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What is GRADE?

• Developed by international guideline developers

• Explicit evaluation of the importance of outcomes

• Explicit, comprehensive criteria for downgrading and upgrading quality of evidence ratings

• Clear separation between quality of evidence and strength of recommendations

Page 33: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

GRADE categorisations – Quality of Evidence

High: • Further research is very unlikely to change our confidence

in the estimate of effect.Moderate:

• Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.

Low: • Further research is very likely to have an important impact

on our confidence in the estimate of effect and is likely to change the estimate.

Very low: • Any estimate of effect is very uncertain.

Page 34: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

GRADE – Strength of recommendations

Strong– desirable effects clearly outweigh

undesirable effects, or the reverse – Most patients will make same decision

about the treatment

Weak – different patients will choose different

approaches to treatment

Page 35: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What GRADE version of CE looks like• Summary

statements rewritten

• Glossary links explain what GRADE scores mean

• Links to GRADE table from each summary statement

Glossary

GRADE Table

Page 36: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

GRADE Table

• Transparent explanation for why points were added/deducted

• Linked to relevant references

Page 37: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Scoring system

Page 38: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Planning

Appraisal

Publish

Searching

BMJ Clinical Evidence Updating Cycle

Does it stop here?

– Repeated every 6 to 12 months

– Updated regularly

Page 39: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

BMJ Updates

Collaboration with McMaster University

Engages over 3,000 clinicians

Systematic survey of over 120 top clinical journals

Page 40: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 41: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Guidelines

Page 42: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 43: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

• What feature in Clinical Evidence will help you determine the quality of an evidence?

Pop Quiz 1:

•Answer: The GRADE Table

Page 44: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Looking back – Traditional Steps of Evidence Based Medicine

• Assess • Ask clinical question• Acquire the

evidence• Appraise the

evidence• Apply the evidence

Systems

Summaries

Synopses

Syntheses

Studies

Examples

Computerized decision support

Evidence-based textbooks

Evidence-based journal abstracts

Systematic reviews

Original journal articles

The evolution of Evidence-Basedinformation systems

Page 45: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What makes a good EBM Summary Database?

• Comprehensive literature search• Pre-appraised

– Appraisal methods– Based around clinical questions and patient outcomes– Inclusion and Exclusion criteria– Preference for systematic reviews over individual studies

• Regularly updated• Easy access and use• Links to original paper

Page 46: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Does BMJ Clinical Evidence “fit the bill”?Comprehensive literature searchPre-appraised

Appraisal methods Based around clinical questions and patient

outcomes Inclusion and Exclusion criteria Preference for systematic reviews over individual

studies Regularly updatedLinks to original paper• Easy access and use

Page 47: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Case Scenario:• You are an inexperienced junior hospital doctor. A 55 year old asthmatic

man who has heart failure attends the out-patient clinic. Despite taking an ACE inhibitor his heart failure is inadequately controlled. You discuss the case with your senior who advises that you add an Angiotensin II reception blocker to his treatment.

• 你是一名年輕的臨床醫生,接診一名 55 嵗男性氣喘者,同時患有心力衰竭。儘管服用血管緊張素轉化酶抑制劑 (ACE Inhibitor) ,但效果不明顯。你的資深同事建議加入血管緊張素 II 受体拮抗劑 (Angiotensin II Reception Blocker) 治療。

• You are worried, having never combined these two types of drugs before, and would like reassurance that this is a reasonable course of action…

• 你擔心自己從沒有混合使用兩种藥物的先例,故希望找到可靠的證據。。。

Page 48: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Where do we start?

Page 49: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 50: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 51: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 52: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 53: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 54: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 55: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Does BMJ Clinical Evidence “fit the bill”?Comprehensive literature searchPre-appraised

Appraisal methods Based around clinical questions and patient

outcomes Inclusion and Exclusion criteria Preference for systematic reviews over individual

studies Regularly updatedLinks to original paperEasy access and use

Page 56: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

• Which of the following are features of Clinical Evidence?A. Covers the benefits and harms of each

interventionB. Summarises the condition based on key

questions asked by clinicians, summary and background of the condition

C. Produced by an international panel of clinicians using rigorous searching and evaluation methods

D. All of the above

Pop Quiz 2:

Page 57: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 58: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

New and Upcoming!- New BMJ Evidence Centre- Upcoming BMJ Best Practice

Page 59: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

The New BMJ Evidence CentreThe new hub of evidence-based medicine…http://group.bmj.com/products/evidence-centre

Page 60: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 61: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 62: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

New in January 2009

Page 63: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

What is BMJ Best Practice ?

• Point of Care tool / Decision Support tool• Combination of Evidence, Expert Opinion and

Guidelines• Common conditions primary & secondary care• Structured and set by step approach• Summary, Basic / Background Info, Prevention,

Diagnosis, Treatments, Evidence, Drugs, follow up & patient info

Page 64: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Key Features:• In-depth coverage of 1000 conditions1

• Action-oriented and structured around the patient consultation

• Advice on symptom evaluation, treatment approach and test ordering

• International perspective, customisable for local needs• Integrated evidence from Clinical Evidence• Critical prescribing information with links to local drug

formulary• Guideline summaries and expert opinion • 192 patient support leaflets• Open URL Compliant

1At launch in January 2009, Best Practice will feature 500 conditions. These will be added to during the course of the year with more than 1000 conditions available by December 2009.

Page 65: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Evidence

Page 66: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager
Page 67: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Evidence > Intervention Table

Page 68: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Condition Overviews

Page 69: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Differential Diagnosis

Page 70: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Step-by-Step (Diagnostic Approach)

Page 71: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Step-by-Step (Treatment Approach)

Page 72: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Images

Page 73: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

My Best Practice

Page 74: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Resource list

• BMJ Clinical Evidence www.clinicalevidence.com• BMJ Updates www.bmjupdates.com• Cochrane Library

www3.interscience.wiley.com/cgi-bin/mrwhome/106568753/HOME?CRETRY=1&SRETRY=0

• PubMed Clinical Queries www.ncbi.nlm.nih.gov/entrez/query/static/clinical.shtml

• National Guidelines Clearing House www.guidelines.gov/• Centre for Evidence based medicine www.cebm.net/index.asp• Centre for Reviews and Dissemination www.york.ac.uk/inst/crd• ScHARR www.shef.ac.uk/scharr/

Page 75: Bringing Evidence into Dju-Lyn Chng 茹玲 Account Development Manager

Thank youDju-Lyn Chng

BMJ [email protected]